Table 1.

Aims of antiretroviral therapy in HIV-related lymphoproliferative diseases.

Reduces HIV-related morbidity and prolong survival Improves the quality of life Restores and preserves immunological function Durably suppresses viral load Restores the immunological status making chemotherapy treatment tolerable also in immunocompromised patients Improves bone marrow reserve by decreasing the negative impact of HIV infection on hematopoiesis Prevents opportunistic infections and HIV-associated complications Allows the use of standard doses of chemotherapy regimens